(HealthDay)—An estimated 14.3 percent of the U.S. population were infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by mid-November 2020, according to a study […]
Mid-term results of the first clinical trial designed specifically to evaluate the safety and effectiveness of two cell therapies that are showing early promise in treating […]